Quick Answer
BIOREGENX, INC. reported Net Income of -$23.05 million for fiscal year 2024.
BIOREGENX, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$23.05M | -540.4% |
| 2023 | -$3.60M | -4497.3% |
| 2022 | -$78.3K | +19.2% |
| 2021 | -$96.9K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$80.6K | +79.6% | +54.8% |
| June 30, 2025 | -$178.3K | +83.9% | +33.2% |
| March 31, 2025 | -$266.9K | +91.5% | +32.4% |
| September 30, 2024 | -$394.9K | +84.3% | +64.3% |
| June 30, 2024 | -$1.11M | -86.1% | +64.9% |
| March 31, 2024 | -$3.15M | -475.2% | -25.1% |
| September 30, 2023 | -$2.52M | -114871.9% | -323.8% |
| June 30, 2023 | -$594.5K | -1687.2% | -8.5% |
- BIOREGENX, INC. showed a decrease of -540.4% in Net Income compared to the prior fiscal year.
- Over the 2021–2024 period, BIOREGENX, INC.’s net income has declined by 23698.2% (from -$96.9 thousand to -$23.05 million).
- The most recent figure is from BIOREGENX, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: